Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Lysine Acetylsalicylate Panpharma 1800mg*


Contraindicated
Starting the 6th month of pregnancy

Not recommended
Lysine Acetylsalicylate Panpharma 1800mg* :
Type Medicine Non Marketed
Originator G
Agent Minapharm Halabi
Distributor Minapharm Halabi
Laboratory Panpharma
Responsible Party Panpharma
Origin France
Manufacturer Panpharma Ind
Manufacturing Type G
Origin France
ATC N02BA01

Your comment will appear shortly after approval

Lysine Acetylsalicylate Panpharma 1800mg* :

Revision Date : 21/10/2016


Effect Frequency
Abdominal pain Not known
Anaphylactic reactions Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Asiderotic anemia Not known
Asthma Not known
Auditory hypoacuity Not known
Bleeding time prolonged Not known
Cephalea Not known
Epistaxis (Nasal bleeding) Not known
Gastric haemorrhage Not known
Gastric perforation Not known
Gastric ulcer Not known
Gingival bleeding (Gingival hemorrhage) Not known
Haematemesis Not known
Injection site pain Not known
Injection site reaction Not known
Melaena Not known
Purpura Not known
Skin reaction Not known
Tinnitus Not known
Urticaria Not known
Vertigo Not known

Different Units By MoH Code

Lysine Acetylsalicylate Panpharma 1800mg*  MoH 2084 :
Form Powder for solution for injection
Packaging Bottle
Package Size 100x5ml
Strength 1800mg
NSSF ✘
Quarantine ✘
Reg. Number B0980/92
Submission date 01/01/1992
Registration Year 1994
Archived Date 2018


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info